Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
1359
mi
from 98109
Omaha, NE
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
1359
mi
from 98109
Omaha, NE
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
882
mi
from 98109
Henderson, NV
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
882
mi
from 98109
Henderson, NV
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
2159
mi
from 98109
Rochester, NY
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
2159
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
2290
mi
from 98109
High Point, NC
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
2290
mi
from 98109
High Point, NC
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigational Site
153
mi
from 98109
Lake Oswego, OR
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigational Site
153
mi
from 98109
Lake Oswego, OR
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis
146
mi
from 98109
Portland, OR
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigational Site
1770
mi
from 98109
Austin, TX
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigational Site
1770
mi
from 98109
Austin, TX
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative site
1684
mi
from 98109
Dallas, TX
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative site
1684
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
2284
mi
from 98109
Charlottesville, VA
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
2284
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from 98109
Nice,
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from 98109
Nice,
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
mi
from 98109
Clinton Township, MI
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
mi
from 98109
Clinton Township, MI
Click here to add this to my saved trials
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated:  12/8/2017
Novartis Investigative Site
1717
mi
from 98109
Saint Louis, MO
AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis
A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis
Status: Enrolling
Updated: 12/8/2017
Novartis Investigative Site
1717
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Childrens Hospital Los Angeles
957
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Axis Clinical Research
959
mi
from 98109
Los Angeles, CA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Axis Clinical Research
959
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Park Avenue Dermatology
2456
mi
from 98109
Orange Park, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Park Avenue Dermatology
2456
mi
from 98109
Orange Park, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Olympian Clinical Research
2525
mi
from 98109
Tampa, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Olympian Clinical Research
2525
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Northwest Clinical Trials
402
mi
from 98109
Boise, ID
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Northwest Clinical Trials
402
mi
from 98109
Boise, ID
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Sneeze, Wheeze & Itch Associates LLC
1712
mi
from 98109
Normal, IL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Sneeze, Wheeze & Itch Associates LLC
1712
mi
from 98109
Normal, IL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
The Dermatology Group, P.C.
2386
mi
from 98109
Verona, NJ
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
The Dermatology Group, P.C.
2386
mi
from 98109
Verona, NJ
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
UNC Dermatology and Skin Cancer Center
2337
mi
from 98109
Chapel Hill, NC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
UNC Dermatology and Skin Cancer Center
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Wake Forest Baptist Health
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Oregon Health and Science University
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
University of Pennsylvania, Department of Dermatology
2373
mi
from 98109
Philadelphia, PA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
University of Pennsylvania, Department of Dermatology
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Temple Itch Center
2373
mi
from 98109
Philadelphia, PA
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Temple Itch Center
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Radiant Research, Inc.
2227
mi
from 98109
Anderson, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Radiant Research, Inc.
2227
mi
from 98109
Anderson, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Medical Research South
2419
mi
from 98109
Charleston, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Medical Research South
2419
mi
from 98109
Charleston, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
National Allergy and Asthma Research, LLC
2409
mi
from 98109
North Charleston, SC
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
National Allergy and Asthma Research, LLC
2409
mi
from 98109
North Charleston, SC
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Dermatology Treatment & Research Center, PA
1675
mi
from 98109
Dallas, TX
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Dermatology Treatment & Research Center, PA
1675
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Sylvana Research Associates
1780
mi
from 98109
San Antonio, TX
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Sylvana Research Associates
1780
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Clinical research Center of Alabama
2081
mi
from 98109
Birmingham, AL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Clinical research Center of Alabama
2081
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Forefront Dermatology
1861
mi
from 98109
Carmel, IN
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Forefront Dermatology
1861
mi
from 98109
Carmel, IN
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Corning Center for Clinical Research
2216
mi
from 98109
Corning, NY
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Corning Center for Clinical Research
2216
mi
from 98109
Corning, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
Tory Sullivan MD PA
2725
mi
from 98109
North Miami Beach, FL
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
Tory Sullivan MD PA
2725
mi
from 98109
North Miami Beach, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated:  12/11/2017
MediSearch Clinical Trials
1469
mi
from 98109
Saint Joseph, MO
Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis
A Phase 2 Multicenter Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Adult Subjects With Pruritus Associated With Atopic Dermatitis
Status: Enrolling
Updated: 12/11/2017
MediSearch Clinical Trials
1469
mi
from 98109
Saint Joseph, MO
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Florida Center for Dermatology, P.A
2452
mi
from 98109
Jacksonville, FL
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Florida Center for Dermatology, P.A
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Atlanta Dermatology, Vein & Research Ctr
2173
mi
from 98109
Alpharetta, GA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Atlanta Dermatology, Vein & Research Ctr
2173
mi
from 98109
Alpharetta, GA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Dermatologic Surgery Specialists, Inc.
2252
mi
from 98109
Macon, GA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Dermatologic Surgery Specialists, Inc.
2252
mi
from 98109
Macon, GA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
The Indiana Clinical Trials Center, PC
1859
mi
from 98109
Plainfield, IN
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
The Indiana Clinical Trials Center, PC
1859
mi
from 98109
Plainfield, IN
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
DermResearch, PLLC
1941
mi
from 98109
Louisville, KY
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
DermResearch, PLLC
1941
mi
from 98109
Louisville, KY
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Mass General Hospital Clinical Unit for Research Trials in Skin
2485
mi
from 98109
Boston, MA
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Mass General Hospital Clinical Unit for Research Trials in Skin
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Derm Research Center of New York, Inc.
2435
mi
from 98109
Stony Brook, NY
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Derm Research Center of New York, Inc.
2435
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Oregon Dermatology & Research Center
146
mi
from 98109
Portland, OR
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Oregon Dermatology & Research Center
146
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Clinical Partners, LLC
2482
mi
from 98109
Johnston, RI
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Clinical Partners, LLC
2482
mi
from 98109
Johnston, RI
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
J&S Studies
1811
mi
from 98109
College Station, TX
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
J&S Studies
1811
mi
from 98109
College Station, TX
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
University of Utah, Dermatology
701
mi
from 98109
Salt Lake City, UT
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
University of Utah, Dermatology
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated:  12/12/2017
Center for Clinical Studies
1912
mi
from 98109
Webster, TX
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled, 4-week Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
Status: Enrolling
Updated: 12/12/2017
Center for Clinical Studies
1912
mi
from 98109
Webster, TX
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 01
2391
mi
from 98109
East Windsor, NJ
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 01
2391
mi
from 98109
East Windsor, NJ
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 02
2289
mi
from 98109
High Point, NC
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 02
2289
mi
from 98109
High Point, NC
Click here to add this to my saved trials
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  12/13/2017
Valeant Site 03
2402
mi
from 98109
New York, NY
Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 12/13/2017
Valeant Site 03
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials